Visceral fat is a clinically significant form of deep abdominal fat linked to serious metabolic and cardiovascular conditions. Unlike subcutaneous fat, it surrounds vital organs and actively disrupts hormonal and metabolic function. Searches for 'John Kim visceral fat' reflect growing public interest in expert-led guidance on understanding and reducing visceral adiposity. This article draws on NHS, NICE, and UK Chief Medical Officers' guidelines to explain what visceral fat is, why it matters, how to assess your risk using validated measures, and what evidence-based steps you can take to protect your long-term health.

What Is Visceral Fat and Why Does It Matter for Your Health?

Visceral fat is stored deep within the abdominal cavity, surrounding vital organs, and is metabolically active — releasing inflammatory mediators that disrupt insulin sensitivity and lipid metabolism. NICE recommends waist circumference and waist-to-height ratio as validated proxy measures in clinical practice.

Visceral fat is a type of body fat stored deep within the abdominal cavity, surrounding vital organs such as the liver, pancreas, and intestines. Unlike subcutaneous fat — the fat you can pinch beneath the skin — visceral fat is metabolically active and plays a significant role in how the body regulates hormones, inflammation, and energy metabolism. Because it sits so close to major organs, its effects on health are considered more clinically significant than fat stored elsewhere in the body.

One of the key reasons visceral fat attracts considerable medical attention is its ability to release pro-inflammatory cytokines and free fatty acids directly into the portal circulation, which feeds the liver. This can disrupt normal metabolic processes and contribute to insulin resistance, elevated blood lipids, and systemic inflammation. Researchers and clinicians — including those working in metabolic health and obesity medicine — have increasingly focused on visceral fat as a primary target for reducing cardiometabolic risk.

Visceral fat cannot be directly measured without specialist imaging. MRI and CT scanning can quantify visceral adipose tissue accurately, but these are research and secondary-care tools — they are not used routinely in primary care due to cost, availability, and, in the case of CT, radiation exposure. DXA (dual-energy X-ray absorptiometry) scanning can provide an estimate of visceral fat and is used in some clinical settings. Consumer body-composition scales that display a 'visceral fat score' are not validated for clinical use and should be interpreted with caution.

In everyday clinical practice, proxy measures are used to assess risk. NICE recommends using waist circumference alongside BMI and, increasingly, the waist-to-height ratio (WHtR) as part of routine cardiovascular and metabolic risk assessment:

Waist circumference thresholds (NICE/NHS):

• Men: above 94 cm — increased risk; above 102 cm — high risk

• Women: above 80 cm — increased risk; above 88 cm — high risk

Waist-to-height ratio (WHtR):

• A WHtR of 0.5 or above indicates increased risk; 0.6 or above indicates substantially elevated risk

• As a practical rule: aim to keep your waist circumference to less than half your height

To measure your waist accurately, find the midpoint between the bottom of your lowest rib and the top of your hip bone (iliac crest), usually around the level of your navel. Measure at the end of a normal breath, without pulling in your stomach. The NHS Live Well pages provide step-by-step guidance on how to measure your waist and interpret your result.

Understanding your visceral fat level is an important first step in taking a proactive approach to long-term health.

Understanding the Risks Associated With Excess Visceral Fat

Excess visceral fat is strongly associated with metabolic syndrome, type 2 diabetes, cardiovascular disease, and certain cancers, and can elevate cardiometabolic risk even when BMI appears normal. Inflammatory markers released by visceral adipose tissue contribute directly to atherosclerosis and endothelial dysfunction.

Excess visceral fat is strongly associated with a cluster of metabolic abnormalities collectively known as metabolic syndrome. This syndrome encompasses raised blood pressure, elevated fasting blood glucose, abnormal blood lipid levels, and central obesity. Individuals with metabolic syndrome face a significantly elevated risk of developing type 2 diabetes, cardiovascular disease, and metabolic dysfunction-associated steatotic liver disease (MASLD, previously known as non-alcoholic fatty liver disease or NAFLD). The NHS recognises central obesity as one of the most modifiable risk factors for these conditions.

The relationship between visceral fat and cardiovascular disease is particularly well-established. Visceral adipose tissue promotes the release of inflammatory markers such as interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-α), which contribute to endothelial dysfunction and atherosclerosis. Studies have shown that individuals with high visceral fat deposits carry an elevated risk of myocardial infarction and stroke, even when their overall body mass index (BMI) falls within a 'normal' range. This pattern — sometimes described in research literature as 'metabolically obese normal weight' — is a research concept rather than a formal clinical diagnosis, but it highlights that BMI alone does not fully capture cardiometabolic risk.

Beyond cardiovascular risk, excess visceral fat has been associated with:

• Type 2 diabetes — through insulin resistance and impaired glucose regulation

• Certain cancers — including colorectal, breast (post-menopausal), and endometrial cancers; Cancer Research UK provides detailed information on the links between excess body weight and cancer risk

• Obstructive sleep apnoea — due to fat deposition around the upper airway and neck; the NHS provides patient-facing information on sleep apnoea risk factors

• Hormonal disruption — including altered oestrogen and testosterone metabolism

• Mental health and cognitive function — observational studies suggest associations between visceral adiposity and depression and cognitive decline, though the evidence is preliminary, causality has not been established, and the relationship may be bidirectional

It is important to note that visceral fat accumulation is influenced by a combination of genetic, hormonal, dietary, and lifestyle factors. Age and sex also play a role, with visceral fat tending to increase after the menopause in women and with advancing age in men.

Evidence-Based Methods for Reducing Visceral Fat

Aerobic exercise, resistance training, and a diet low in refined carbohydrates and saturated fats are the most evidence-based strategies for reducing visceral fat. UK CMO guidelines recommend at least 150 minutes of moderate-intensity aerobic activity per week alongside muscle-strengthening on two or more days.

Visceral fat is generally more responsive to lifestyle intervention than subcutaneous fat. A consistent body of evidence supports the effectiveness of combined dietary modification and regular physical activity in reducing visceral adiposity, often before significant changes in overall body weight become apparent.

Aerobic exercise is one of the most well-evidenced strategies for reducing visceral fat. Multiple systematic reviews and meta-analyses indicate that moderate-to-vigorous aerobic activity — such as brisk walking, cycling, swimming, or jogging — can reduce visceral fat, even when overall weight loss is modest. The UK Chief Medical Officers' Physical Activity Guidelines (2019) recommend that adults aim for:

• At least 150 minutes of moderate-intensity aerobic activity per week, or 75 minutes of vigorous-intensity activity, or an equivalent combination

• Muscle-strengthening activities (such as resistance exercise, yoga, or heavy gardening) on at least two days per week

• Reduction of prolonged sedentary time, breaking up long periods of sitting throughout the day

These targets align with NICE guidance on physical activity for weight management (PH53).

Resistance training contributes to visceral fat reduction by increasing lean muscle mass and improving insulin sensitivity. A combination of aerobic and resistance exercise appears to be more effective than either modality alone. High-intensity interval training (HIIT) has shown promising results in clinical trials, though it may not be appropriate for all individuals — particularly those with cardiovascular conditions — and should be introduced gradually.

From a dietary perspective, reducing overall energy intake — particularly from refined carbohydrates, added sugars, and saturated fats — is associated with meaningful reductions in visceral fat. Diets rich in fibre, lean protein, and unsaturated fats (such as the Mediterranean dietary pattern) have demonstrated particular benefit in clinical research.

Sleep quality and stress management are associated with visceral fat accumulation. Observational evidence suggests that chronic sleep deprivation and persistently elevated cortisol levels may promote central adiposity, though the relationship is complex and likely bidirectional. Addressing sleep hygiene and stress as part of an overall lifestyle approach is reasonable, even if the independent contribution of these factors remains an area of ongoing research.

Diet and Lifestyle Changes Recommended by UK Health Guidelines

The NHS Eatwell Guide and NICE guidance recommend a diet rich in fruit, vegetables, wholegrains, lean protein, and unsaturated fats, combined with regular physical activity and alcohol intake limited to no more than 14 units per week. Behavioural change support and structured weight management programmes are also recommended for sustained results.

UK health guidelines, including those from NICE (CG189 — Obesity: identification, assessment and management) and the NHS Eatwell Guide, provide a clear framework for dietary and lifestyle changes that support healthy body composition and visceral fat reduction. These recommendations are grounded in population-level evidence and are applicable to the majority of adults.

The NHS Eatwell Guide recommends a diet based on:

• Plenty of fruit and vegetables — at least five portions per day

• Starchy carbohydrates — preferably wholegrain varieties for their higher fibre content

• Lean proteins — including fish, pulses, eggs, and lower-fat dairy

• Healthy unsaturated fats — from sources such as olive oil, nuts, and avocados

• Limited intake of foods high in saturated fat, salt, and free sugars

NICE guidance (PH53) also emphasises the importance of behavioural change support in achieving sustainable weight management. This includes goal-setting, self-monitoring (such as keeping a food diary or using a validated app), and addressing psychological barriers to change. Referral to structured weight management programmes — such as those offered through NHS Tier 2 services — may be appropriate for individuals who have not achieved results through self-directed efforts.

In addition to dietary changes, the UK Chief Medical Officers' Physical Activity Guidelines (2019) recommend at least 150 minutes of moderate-intensity aerobic activity per week, muscle-strengthening activities on at least two days per week, and reducing prolonged sedentary time. These targets complement dietary changes and are central to managing visceral fat and overall cardiometabolic risk.

Alcohol consumption is another modifiable factor. Excess alcohol intake is directly associated with increased visceral fat deposition. The UK Chief Medical Officers' Low Risk Drinking Guidelines advise limiting alcohol to no more than 14 units per week, spread across at least three days, with several alcohol-free days each week. Keeping within these limits supports both liver health and healthy body composition.

Smoking cessation significantly reduces overall cardiometabolic risk and should be encouraged alongside other lifestyle changes. It is worth noting that some people experience modest weight changes after stopping smoking; however, the cardiometabolic benefits of cessation substantially outweigh any such effects. NHS Stop Smoking Services (Smokefree) offer free, evidence-based support to help people quit.

When to Seek Medical Advice About Visceral Fat Levels

See your GP if your waist circumference exceeds 102 cm (men) or 88 cm (women), your WHtR is 0.5 or above, or you have risk factors such as type 2 diabetes or hypertension. GPs can arrange HbA1c, lipid profile, and blood pressure assessment aligned with NICE guidelines NG28 and NG238.

Whilst lifestyle modification is the cornerstone of visceral fat management, there are circumstances in which it is important to seek professional medical advice. A GP can provide a comprehensive assessment of cardiometabolic risk, arrange relevant investigations, and discuss whether additional interventions — including pharmacological treatment — may be appropriate.

You should consider speaking to your GP if:

• Your waist circumference exceeds the high-risk thresholds (above 102 cm for men; above 88 cm for women)

• Your waist-to-height ratio is 0.5 or above — particularly if it is 0.6 or above

• You have a BMI above 30 kg/m², or above 27.5 kg/m² if you are of South Asian, Chinese, or Black African or Caribbean family background (NICE recognises lower intervention thresholds for these groups)

• You have been diagnosed with, or are at risk of, type 2 diabetes, hypertension, or cardiovascular disease

• You have experienced unexplained fatigue, increased thirst, frequent urination, or other symptoms that may suggest metabolic dysfunction

• You have made sustained lifestyle changes over three to six months without meaningful improvement in waist circumference or metabolic markers

Your GP may arrange investigations to build a complete picture of your metabolic health. In UK practice, HbA1c is typically used as the first-line test for glycaemic assessment (with fasting plasma glucose used where HbA1c is unsuitable, for example in certain haematological conditions). A non-fasting lipid profile is standard for initial cardiovascular risk assessment, unless there is a specific clinical reason to request a fasting sample (for example, if triglycerides are very high). Blood pressure measurement and liver function tests may also be arranged where relevant. These approaches align with NICE guidance on type 2 diabetes (NG28) and cardiovascular risk assessment and lipid modification (NG238).

In some cases, referral to a specialist may be recommended — for example, to a Tier 3 specialist weight management service, an endocrinologist, a registered dietitian, or a bariatric surgery service. NICE sets out criteria for referral to bariatric surgery, which is considered for adults with a BMI of 40 kg/m² or above, or 35 kg/m² or above with a significant obesity-related condition, who have not achieved adequate weight loss through other interventions.

It is worth noting that there is no official clinical link between any specific named individual and visceral fat management guidelines; always rely on NHS- and NICE-endorsed sources for health guidance.

NHS and NICE Resources for Managing Healthy Body Composition

The NHS offers free tools including the 12-week NHS Weight Loss Plan, NHS Eatwell Guide, and Diabetes Prevention Programme, while NICE guidelines CG189, PH53, NG28, and NG238 provide the clinical framework for visceral fat and body composition management.

The NHS and NICE offer a wide range of freely accessible, evidence-based resources to support individuals in managing their body composition and reducing visceral fat. These tools are designed to complement professional medical advice and empower individuals to make informed, sustainable changes.

Key NHS resources include:

• NHS Weight Loss Plan — a free 12-week programme available via the NHS website and app, providing structured dietary and physical activity guidance

• NHS Eatwell Guide — a visual tool outlining recommended food group proportions for a balanced diet

• NHS Better Health campaign — offering practical tools for weight management, physical activity, and smoking cessation

• NHS Diabetes Prevention Programme — for individuals identified as being at high risk of type 2 diabetes, offering personalised lifestyle support

• NHS Live Well: Waist size and BMI — patient-facing guidance on how to measure your waist accurately and interpret your result

• NHS Smokefree (Stop Smoking Services) — free, evidence-based support for smoking cessation

• NHS Obstructive Sleep Apnoea information — guidance on OSA risk factors, symptoms, and when to seek help

NICE guidance relevant to visceral fat and body composition includes:

• CG189 — Obesity: identification, assessment and management (including updated recommendations on waist-to-height ratio)

• PH53 — Managing overweight and obesity in adults: lifestyle weight management services

• NG28 — Type 2 diabetes in adults: management

• NG238 — Cardiovascular disease: risk assessment and reduction, including lipid modification

UK Chief Medical Officers' Guidelines:

• UK CMO Physical Activity Guidelines (2019) — authoritative UK targets for aerobic activity, muscle-strengthening, and reducing sedentary behaviour

• UK CMO Low Risk Drinking Guidelines — guidance on alcohol consumption limits

For those seeking additional support, Cancer Research UK (on weight and cancer risk), Diabetes UK, Heart UK, and the British Dietetic Association (BDA) all provide patient-facing resources aligned with UK clinical guidelines. It is advisable to approach online health information critically and to prioritise sources endorsed by recognised UK health bodies. If you are unsure whether a particular dietary approach, supplement, or programme is appropriate for your individual circumstances, always consult a registered healthcare professional before making significant changes to your health regimen.

Frequently Asked Questions